Brought to you by 
Japan’s RaQualia Pharma goes public on Jasdaq
04 Aug 2011
Executive Summary
RaQualia Pharma Inc. (drug discovery), a 2008 Pfizer spin-out, has gone public on the Osaka Stock Exchange’s Jasdaq netting Y5.92bn ($74.9mm) through the sale of 4mm shares at Y1,600, the low end of its anticipated Y1,600-2,000 range. The company had originally anticipated completing a 3.7mm-share IPO during the first quarter of the year, but had to postpone it because of the poor Japanese market conditions resulting from the destructive early March earthquake and tsunami.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Japan’s RaQualia Pharma goes public on Jasdaq
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice